G6PD and hepatocellular carcinoma: Reports suggested that G6PD OE in hepatocellular carcinoma or ccRCC was mediated by Nrf2 or through synergistic overactivation of the NF-κB and pSTAT3 signaling pathways, respectively (18, 35).